Zhongliu Fangzhi Yanjiu (May 2023)

Progress of Different Programmed Cell Death Pathways in Kidney Cancer

  • WU Mingzhe,
  • WANG Fuchun,
  • PAN Haojie,
  • ZHOU An'an,
  • XIAO Xi,
  • TIAN Junqiang

DOI
https://doi.org/10.3971/j.issn.1000-8578.2023.22.1100
Journal volume & issue
Vol. 50, no. 5
pp. 531 – 537

Abstract

Read online

Programmed cell death (PCD) is a genetically determined, active and orderly cell death in the organism, and it affects the evolution of the organism, maintenance of its homeostasis, and development of several tissues and organs. The abnormal regulation of this process is closely related to various human diseases, including cancer. The identified pathways of PCD include apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis, which can be activated when cells are stimulated by various internal and external environmental factors. These pathways can induce cell death or maintain cell survival in kidney cancer cells under the regulation of various signaling molecules, thus affecting tumor progression or therapeutic efficacy. In this paper, the role of these PCD pathways in the development of kidney cancer was reviewed in light of recent research advances to provide new directions for the in-depth study of the pathogenesis of kidney cancer and the development of targeted antitumor drugs.

Keywords